机构：[1]Department of Thoracic Surgery and Oncology, The First Affiliated Hospital ofGuangzhou Medical University, Guangzhou, China[2]Oncology, State Key Laboratory ofRespiratory Diseases - The First Affiliated Hospital of Guangzhou Medical University,Guangzhou, China[3]Department of Thoracic Surgery, The First Affiliated Hospital ofGuangzhou Medical University, Guangzhou, China[4]Guangdong Provincial Hospital ofChinese Medicine, Guangzhou, China[5]Department of Thoracic Surgery and Oncology,Guangzhou Medical University, Guangzhou, China[6]Department of Thoracic Surgery,The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China[7]Thoracic Oncology Dept., Guangzhou Medical University, Guangzhou, China[8]Department of Thoracic Surgery, State Key Laboratory of Respiratory Diseases - TheFirst Affiliated Hospital of Guangzhou Medical University, Guangzhou, China[9]TheFirst Affiliated Hospital of Guangzhou Medical University, Guangzhou, China[10]Thoracic Oncology, The First Affiliated Hospital of Guangzhou Medical University,Guangzhou, China
第一作者机构：[1]Department of Thoracic Surgery and Oncology, The First Affiliated Hospital ofGuangzhou Medical University, Guangzhou, China
推荐引用方式(GB/T 7714)：
X. Liu,R. Zhong,J. Huang,et al.Loratadine: A potential game-changer in lung cancer treatment with improved survival outcomes[J].ANNALS OF ONCOLOGY.2023,34:S752-S753.doi:10.1016/j.annonc.2023.09.787.
APA：
X. Liu,R. Zhong,J. Huang,Z. Chen,H. Xu...&J. He.(2023).Loratadine: A potential game-changer in lung cancer treatment with improved survival outcomes.ANNALS OF ONCOLOGY,34,
MLA：
X. Liu,et al."Loratadine: A potential game-changer in lung cancer treatment with improved survival outcomes".ANNALS OF ONCOLOGY 34.(2023):S752-S753
医学